These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36048309)

  • 21. Using Behavioral Economics to Support PrEP Adherence for HIV Prevention.
    Roy Paladhi U; Katz DA; Farquhar C; Thirumurthy H
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):409-414. PubMed ID: 36044119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus Infection.
    Browne SH; Vaida F; Umlauf A; Tucker AJ; Blaschke TF; Benson CA
    Clin Infect Dis; 2023 Jan; 76(1):134-143. PubMed ID: 36484300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.
    Marcus JL; Buisker T; Horvath T; Amico KR; Fuchs JD; Buchbinder SP; Grant RM; Liu AY
    HIV Med; 2014 Aug; 15(7):385-95. PubMed ID: 24580813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions.
    Bazzi AR; Drainoni ML; Biancarelli DL; Hartman JJ; Mimiaga MJ; Mayer KH; Biello KB
    BMC Public Health; 2019 Jan; 19(1):31. PubMed ID: 30621657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.
    Cáceres CF; Borquez A; Klausner JD; Baggaley R; Beyrer C
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21108. PubMed ID: 27760685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP".
    Mayer KH; Safren SA; Elsesser SA; Psaros C; Tinsley JP; Marzinke M; Clarke W; Hendrix C; Wade Taylor S; Haberer J; Mimiaga MJ
    AIDS Behav; 2017 May; 21(5):1350-1360. PubMed ID: 27848089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
    Mayer KH; Agwu A; Malebranche D
    Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formative acceptance of ingestible biosensors to measure adherence to TB medications.
    Vaz C; Jose NK; Tom JJ; Goodman GR; Lee JS; Padappayil RP; Madathil M; O'Cleirigh C; Rodrigues R; Chai PR
    BMC Infect Dis; 2022 Sep; 22(1):754. PubMed ID: 36171553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
    Roberts ST; Haberer J; Celum C; Mugo N; Ware NC; Cohen CR; Tappero JW; Kiarie J; Ronald A; Mujugira A; Tumwesigye E; Were E; Irungu E; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):313-322. PubMed ID: 27243900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining information to estimate adherence in studies of pre-exposure prophylaxis for HIV prevention: Application to HPTN 067.
    Hughes JP; Williamson BD; Krakauer C; Chau G; Ortiz B; Wakefield J; Hendrix C; Amico KR; Holtz TH; Bekker LG; Grant R
    Stat Med; 2022 Mar; 41(6):1120-1136. PubMed ID: 35080038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?
    Sidebottom D; Ekström AM; Strömdahl S
    BMC Infect Dis; 2018 Nov; 18(1):581. PubMed ID: 30445925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.
    Castillo-Mancilla JR; Haberer JE
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):49-59. PubMed ID: 29380227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I Can See Clearly Now: Using Active Visualisation to Improve Adherence to ART and PrEP.
    Jones AS; Petrie KJ
    AIDS Behav; 2017 Feb; 21(2):335-340. PubMed ID: 27873082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.
    Garrison LE; Haberer JE
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S73-S86. PubMed ID: 34686294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility, Acceptability, and Preliminary Efficacy of a Gamified Mobile Health Contingency Management Intervention for PrEP Adherence Among Black MSM.
    Mitchell JT; Burns CM; Atkinson B; Cottrell M; Frye JK; McKellar MS; Kashuba ADM; McClernon FJ; Okeke NL
    AIDS Behav; 2022 Oct; 26(10):3311-3324. PubMed ID: 35416595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.